Human Primary Diabetic Liver Vein Endothelial Cells
Quick Actions
Product Overview
Description
Human Primary Diabetic Liver Vein Endothelial Cells are a powerful preclinical tool that bridges the gap between simple cell culture and complex human disease. By retaining the epigenetic and functional memory of the diabetic environment, they allow researchers to study the progression of vascular complications in the liver with high physiological relevance.
Guarantee expansion for a minimum of 2-5 population
doublings.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPD012
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization Markers
Positive for endothelial markers: Positive for endothelial cell
markers: CD31 (PECAM-1) and VE-Cadherin by
immunofluorescence staining or FACS .
- Cells are pre-coated with PECAM-1 antibody during isolation using magnetic beads.
Quick Facts
Product Type
Human Type II Diabetes Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
